Extensive soft-tissue involvement by plasmablastic myeloma arising from displaced humeral fractures

European Journal of Haematology

Volumn 85, Issue 5, 2010, Pages 448-451

  De Larrea, Carlos Fernández ^a   Rosiñol, Laura ^a   Cibeira, María Teresa ^a   Rozman, María ^a   Rovira, Montserrat ^a   Bladé, Joan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Fracture; Multiple myeloma; Plasmacytoma; Surgery

Indexed keywords

BORTEZOMIB; CALCIUM; CARMUSTINE; CD38 ANTIGEN; CD56 ANTIGEN; CD79B ANTIGEN; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; HEMOGLOBIN; IMMUNOGLOBULIN LAMBDA CHAIN; LACTATE DEHYDROGENASE; M PROTEIN; MELPHALAN; PEGINTERFERON ALPHA2B; PREDNISONE; PROTEIN; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE PAIN; BONE RADIOGRAPHY; CALCIUM BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RELAPSE; CASE REPORT; CLIVUS PLASMACYTOMA; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DIAPHYSIS; FEVER; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMERUS FRACTURE; IGG LAMBDA MULTIPLE MYELOMA; IMMUNOPHENOTYPING; LACTATE DEHYDROGENASE BLOOD LEVEL; LOW BACK PAIN; MAINTENANCE THERAPY; MALE; MULTIPLE MYELOMA; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSYNTHESIS; PLASMACYTOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SACRUM PLASMACYTOMA; SHOULDER PAIN; SOFT TISSUE; TREATMENT RESPONSE;

ADULT; FRACTURES, BONE; HUMANS; HUMERUS; MALE; MULTIPLE MYELOMA; NEOPLASM INVASIVENESS; ORTHOPEDIC PROCEDURES; SOFT TISSUE NEOPLASMS;

EID: 77958592162     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01504.x     Document Type: Article

References (12)

1. Kyle RA, Rajkumar SV. Multiple myeloma. Blood 2008;111:2962-72.
2. Wu P, Davies FE, Boyd K, Thomas K, Dines S, Saso RM, Potter MN, Ethell ME, Shaw BE, Morgan GJ. The impact of extramedullary disease at presentation in the outcome of myeloma. Leuk Lymphoma 2009;50:230-5.
3. Varettoni M, Corso A, Pica G, Mangiacavalli S, Pascutto C, Lazzarino M. Incidence, presenting features and outcome of extramedullary disease in myltiple myeloma: a longitudinal study on 10003 consecutive patients. Ann Oncol 2010;21:325-30.
4. Lenhoff S, Hjorth M, Turesson I, et al. Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation. Haematologica 2006;91:1228-33.
5. Alegre A, Granda A, Martínez-Chamorro C, et al. Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from Spanish registry. Hematologica 2002;87:609-14.
6. Zeiser R, Deshler B, Bertz H, Finke J, Engelhardt M. Extramedullary vs medullary relapse ater autologous or allogenic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome. Bone Marrow Transplant 2004;34:1057-65.
7. Byrne JL, Fairbain J, Davy B, Carter IG, Bessell EM, Russell NH. Allogenic transplantation for multiple myeloma: late relapse may occur as localized lytic lesion/plasmocytoma despite ongoing molecular remission. Bone Marrow Transplant 2003;31:157-61.
8. Terpos E, Rezvani K, Basu S, Milne AE, Rose PE, Scott GL, Rahemtulla A, Samson D, Apperley JF. Plasmocytoma relapses in the absence of systemic progression post-high-dose therapy for multiple meeloma. Eur J Haematol 2005;75:376-83.
9. Ah-Weng A, Charles-Holmes R, Rose P, Basu S, Marsden JR, Sanders DS. Multiple cutaneous plasmocytomas following an autologous peripheral stem cell transplant. Clin Exp Dermatol 2002;27:293-5.
10. Trullemans F, Schots R, Storme G, Van Camp B. Late and localized extramedullary relapse of a light chain kappa myeloma after syngenic bone marrow transplantation. Bone Marrow Transplant 2000;25:115-7.
11. Vande Broek I, Vanderkerken K, Van Camp B, Van Riet I. Extravasation and homing mechanisms in multiple myeloma. Clin Exp Metastasis 2008;25:325-34.
12. Huang SY, Tien HF, Su FH, Hsu SM. Nonirradiated NOD/SCID-human chimeric animal model for primary human multiple myeloma: a potential in vivo culture system. Am J Pathol 2004;164:747-56.